Literature DB >> 28820969

A disulfide-stabilized human VL single-domain antibody library is a source of soluble and highly thermostable binders.

Kevin A Henry1, Hiba Kandalaft1, Michael J Lowden1, Martin A Rossotti2, Henk van Faassen1, Greg Hussack1, Yves Durocher3, Dae Young Kim1, Jamshid Tanha4.   

Abstract

We have previously shown that incorporation of a second intradomain disulfide linkage into camelid VHH and human VH/VL single-domain antibodies confers increased thermostability. Here, we explored the effects of introducing an additional disulfide linkage, formed between Cys48 and Cys64 (Kabat numbering), into a phage-displayed synthetic human VL library. In comparison to an identical library bearing only the highly conserved Cys23-Cys88 disulfide linkage, the disulfide-stabilized VL library tolerated a similar degree of randomization but retained a higher level of functional diversity after selection with protein L. Both libraries yielded soluble, antigen-specific VLs that recognized a model antigen (maltose-binding protein) with similar affinities, in the micromolar range; however, the disulfide-stabilized antigen-specific VLs were much more thermostable (average ΔTm ∼10°C) than non-disulfide-stabilized VLs. This work provides proof-of-concept for building synthetic antibody libraries using disulfide-constrained immunoglobulin domains, thus avoiding pitfalls of post-hoc disulfide linkage engineering such as impaired antigen binding and reduced expression yield. Crown
Copyright © 2017. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Disulfide bond; Human V(L); Phage display; Protein engineering; Single-domain antibody; Thermostability

Mesh:

Substances:

Year:  2017        PMID: 28820969     DOI: 10.1016/j.molimm.2017.07.006

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  5 in total

1.  Evaluation of a noncanonical Cys40-Cys55 disulfide linkage for stabilization of single-domain antibodies.

Authors:  Dae Young Kim; Hiba Kandalaft; Greg Hussack; Shalini Raphael; Wen Ding; John F Kelly; Kevin A Henry; Jamshid Tanha
Journal:  Protein Sci       Date:  2019-03-14       Impact factor: 6.725

2.  Neutralization of Clostridium difficile toxin B with VHH-Fc fusions targeting the delivery and CROPs domains.

Authors:  Greg Hussack; Shannon Ryan; Henk van Faassen; Martin Rossotti; C Roger MacKenzie; Jamshid Tanha
Journal:  PLoS One       Date:  2018-12-12       Impact factor: 3.240

Review 3.  Advances in the Production and Batch Reformatting of Phage Antibody Libraries.

Authors:  Rose H Reader; Robert G Workman; Ben C Maddison; Kevin C Gough
Journal:  Mol Biotechnol       Date:  2019-11       Impact factor: 2.695

Review 4.  Central Nervous System Delivery of Antibodies and Their Single-Domain Antibodies and Variable Fragment Derivatives with Focus on Intranasal Nose to Brain Administration.

Authors:  Arghavan Soleimanizadeh; Heiko Dinter; Katharina Schindowski
Journal:  Antibodies (Basel)       Date:  2021-11-30

5.  Stability-Diversity Tradeoffs Impose Fundamental Constraints on Selection of Synthetic Human VH/VL Single-Domain Antibodies from In Vitro Display Libraries.

Authors:  Kevin A Henry; Dae Young Kim; Hiba Kandalaft; Michael J Lowden; Qingling Yang; Joseph D Schrag; Greg Hussack; C Roger MacKenzie; Jamshid Tanha
Journal:  Front Immunol       Date:  2017-12-12       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.